OC-0275 Safety and efficacy of concurrent SRT and targeted- or immunotherapy for melanoma brain metastases. (April 2019) - Heitmann, J.; Kroeze, S.G.C.; Blanck, O.; Kahl, K.H.; Gerum, S.; Combs, S.E.; Kaul, D.; Claes, A.; Schymalla, M.; Grosu, A.; Eckert, F.; Lohaus, F.; et al.